CoChat

Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial

Shah, Sonal, Bell, Robin J., Savage, Greg, Goldstat, Rebecca, Papalia, Mary-Anne, Kulkarni, Jayashri, Donath, Susan, Davis, Susan R. · 2006 · Menopause
Cited by 44

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

In Brief Objective: To explore whether inhibition of the conversion of testosterone to estradiol modifies the effects of testosterone on cognition in 61 healthy, estrogen-treated postmenopausal women. Design: Seventy-six postmenopausal women using transdermal estrogen for at least 8 weeks, with a serum total testosterone less than 1.2 nmol/L participated in a single-center, double-blind, randomized, placebo-controlled study. All participants received transdermal testosterone, 400 μL of a 0.5% testosterone gel, daily and were randomized to receive either letrozole 2.5 mg/day or an identical placebo tablet. The main outcome measure was cognition, evaluated using a comprehensive battery of standardized neuropsychological tests, at baseline and week 16. Results: Thirty women in each group completed the study. Free testosterone increased from baseline in both groups, with no difference between groups. Free testosterone levels achieved were below the 90th centile for young women in 80% of the participants at week 16. Serum estradiol and sex hormone-binding globulin levels did not differ from baseline or between groups during the study. No clinically significant effects of testosterone treatment were seen for attention and working memory, psychomotor speed, or executive function. Significant improvements were seen for immediate and delayed visual and verbal memory and for simple concentration with testosterone therapy, all of which were unaffected by the aromatase inhibitor. Conclusions: We did not observe any effects of aromatase inhibition on cognition in healthy, estrogen-treated postmenopausal women treated with testosterone. This may be due to insufficient study power or a true lack of effect. However, our findings highlight that the detection of subtle changes in cognition in well women require the development of sensitive instruments and large randomized, controlled trials. The effects of testosterone with and without an aromatase inhibitor on cognition in healthy, estrogen-treated postmenopausal women has been explored in a randomized, placebo-controlled trial. No clinically significant effects of concurrent testosteron therapy and aromatase inhibition were seen for attention and working memory, psychomotor speed, executive function, immediate and delayed visual and verbal memory, or for simple concentration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.gme.0000227333.50867.4e

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 44

Metadata

Authors
Shah, S., Bell, R. J., Savage, G., Goldstat, R., Papalia, M.-A., Kulkarni, J., Donath, S., & Davis, S. R.
Venue
Menopause
Published
2006-07
Volume
13
Issue
4
Pages
600-608
ISSN
1072-3714 (ISSN-L)
OpenAlex
W2017191963
Cited by
44
References
11
FWCI
1.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial. https://app.cochat.ai/papers/10.1097/01.gme.0000227333.50867.4e
The paper
Shah, S., Bell, R. J., Savage, G., Goldstat, R., Papalia, M.-A., Kulkarni, J., Donath, S., & Davis, S. R. (2006). Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial. Menopause. https://doi.org/10.1097/01.gme.0000227333.50867.4e

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.